Parth Desai

Partner

2024 - Current

Lead Investor and/or Support for: +SmarterDx (Board Member) - AI to optimize the financial value of clinical data +Photon Health (Board Observer) - AI to power high-value patient & provider pharmacy experiences +Positive Development (Board Observer) - Technology enabled autism care provider +Suki AI - AI-powered digital assistant for physicians +Birch AI (Acquired by Sagility | Board Observer) - Generative AI to automate call center workflows +Jaide Health - Generative AI to automate real-time medical language translation +BeMe Health (Board Observer) - Mobile platform improving teen mental health & well-being +Aetion - Real-world evidence analytics platform to biopharma, payers and regulators +HealthVerity - Data marketplace to connect & exchange real world data +Beaming Health - Marketplace connecting families of children with IDDs to the best care +Rosarium Health - Marketplace connecting service providers to home care +Helm Health - Data and technology driven plan design

Principal

2020 - 2024

Senior Associate

2019 - 2020

Investor, NYP Ventures

2018 - 2019

Investor: Saykara (Acquired by Microsoft | Seed Investor), Syllable AI (Series A Investor) and Workfusion (Series D Investor). Identified innovation priorities and built collaborative relationships with emerging businesses, leveraging internal expertise to support the development and growth of breakthrough technologies to improve the patient and physician experiences of care. Supported $40M strategic fund, led the investment process for several emerging technologies (RPA, ML, NLP), to improve healthcare operations, and supported structuring and scaling commercial partnerships with these companies. Promoted from Senior Associate (2018) to Manager (2019).

Senior Consultant

2013 - 2017

SENIOR CONSULTANT (2016) Led teams advising corporate executives on growth strategy, strategic M&A and innovation within the health care industry. CONSULTANT (2013 to 2015) Developed corporate strategies, supported M&A due diligence analyses and developed performance improvement plans for health industry executives, private equity firms and state governments. Elected, based on performance, to internal leadership position as the firm's National Direct Hire Consultant (DHC) Co-Chair and tasked with managing a council of high-performing peers to enhance the consulting practice's performance.

Research Analyst, Committee on Public Health

2011 - 2013

Led nationally-recognized legislative effort to reform oversight of the pharmaceutical industry for Chairman Jeff Sanchez, in response to a national outbreak of fungal meningitis. Worked with local and national stakeholders to author legislation that was eventually signed into law by Governor Deval Patrick as Chapter 159 of the Acts of 2014. Appointed to the NCSL Health and Human Services Committee.